The following Journal will discuss the use of disease-mofifying antirheumatic drugs and the biologic-therapies in the Dactylitis of third and fourth toes treatment of moderate to severe psoriatic arthritis.

You will find any usefull informations regarding psoriatic arthritis (PsA) since it covers sections such the Pathogenesis of Psoriatic Arthritis, Moll and Wright criteria for psoriatic arthritis, CASPAR criteria for the diagnosis of psoriatic arthritis, The prognosis of PsA, The Classification, Definition of mild, moderate, and severe psoriatic arthritis, Comparison of PsA with rheumatoid arthritis, osteoarthritis, and anklyosing spondylitis, PsA Response Criteria, Radiologic Features and etc.

Also there are descriptions about American College of Rheumatology scoring (ACR), The Disease Activity Score (DAS) scoring system, Scoring methods for the assessment of structural damage in peripheral joints in PsA, and the Use of Disease-Modifying Antirheumatic Drugs (DMARDs)to Treat Moderate to Severe PSA (methotrexate, Sulfasalazine, Leflunomide, TNF inhibitors).

See more complete about Biologic Therapies in the Treatment of Psoriatic Arthritis in this 2008 Psoriasis Journal (source: aad.org)